DURATA THERAPEUTICS INC COM STK (DE)
DRTX
DRTX was delisted on the 17th of November, 2014.
0 hedge funds and large institutions have $0 invested in DURATA THERAPEUTICS INC COM STK (DE) in 2014 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 69 closing their positions.
100% less funds holding
Funds holding: 70 → 0 (-70)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $172M → $0 (-$172M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 69
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Aisling Capital
New York
|
-$25.7M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$25.4M |
| 3 |
CPV
Canaan Partners VII
Westport,
Connecticut
|
-$24.1M |
| 4 |
O
OrbiMed
New York
|
-$22.6M |
| 5 |
O
OppenheimerFunds
New York
|
-$12.7M |
DRTX Hedge Fund Activity: Q4 2014 in Review
0 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in DURATA THERAPEUTICS INC COM STK (DE) (DRTX) for Q4 2014, worth a combined $0 — down 100% from $172M a quarter earlier.
Sellers outnumbered buyers: 69 funds closed out of DRTX and 0 opened new positions — a net loss of 69 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Aisling Capital, exiting entirely with an estimated $25.7M sold.
- 0 institutional investors held DURATA THERAPEUTICS INC COM STK (DE) (DRTX) as of Q4 2014, down from 70 in Q3 2014.
- Funds reported $0 of DURATA THERAPEUTICS INC COM STK (DE) stock for Q4 2014, down 100% quarter-over-quarter.
- 0 funds opened new DURATA THERAPEUTICS INC COM STK (DE) positions in Q4 2014 and 69 closed out, a net change of -69 holders.
- The largest DURATA THERAPEUTICS INC COM STK (DE) seller in Q4 2014 was Aisling Capital, an estimated $25.7M sold.
Based on aggregated 13F filings for Q4 2014.